Skip to main content
Clinical Trials/IRCT201511064166N6
IRCT201511064166N6
Completed
未知

Visual acuity and central macular thickness in the hemorrhagic choroid neo-vascularization due to age-related macular degeneration with intravitreal Avastin injection compared with intravitreal injection of tissue plasminogen activator with avastin

Tabriz University of Medical Sciences-Vice Chancellor for Research and Technology0 sites54 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Age related macular degeneration.
Sponsor
Tabriz University of Medical Sciences-Vice Chancellor for Research and Technology
Enrollment
54
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tabriz University of Medical Sciences-Vice Chancellor for Research and Technology

Eligibility Criteria

Inclusion Criteria

  • hemoragic CNV due to AMD; early onset of symptom in the last month; history of good visual acuity in affected eye
  • Exclusion criteria: history of vitroretinal surgery; uveitis with vitroretinal impairment; corneal disease for example keratoconous, dystrophy and degeneration; any medial hazeness for example vitrous hemorrhage, significant cataract ,...; pathologic myopia; diabetic retinopathy macular edema, retinal detachment, retinal vascular disorder; significant optic nerve injury

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials